Phrontline Biopharma
PrivateLast Round
pre_series_a_plus
Nov 25, 2025
Total Funding Raised
$60M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Phrontline Biopharma is a biotechnology company that develops innovative antibody-drug conjugates (ADCs) to address unmet medical needs in oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phrontline Biopharma Comparables
Compare Phrontline Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allink Biotherapeutics | 88% | |
| Elikya Therapeutics | 85% | |
| Eli Lilly and Company | 84% | |
Phrontline Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| pre_series_a_plus | Nov 25, 2025 | ||||
| Early Funding | Nov 21, 2025 | ||||
| VC Round | Dec 25, 2023 | ||||
| Angel | Mar 10, 2022 |
Phrontline Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Early Funding, pre_series_a_plus |
| Lapam Capital | pre_series_a_plus |
| Samsung Venture Investment | Early Funding, pre_series_a_plus |
| C&D Emerging Industry Equity Investment | pre_series_a_plus |
| Medfine Capital | VC Round, Angel, pre_series_a_plus |
| Samsung Venture Investment | pre_series_a_plus |
| Hankang Capital | pre_series_a_plus |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2025
Raised $60M in a pre-Series A+ round.
- Nov 21, 2025
$60M raised with participation from Samsung Venture Investment.
Phrontline Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phrontline Biopharma's valuation, stock price, and market status.